United States· US:66215-602_7c54a125-9778-41f5-b92c-181711e22e06
UPTRAVI
A medicinal product containing selexipag, registered in United States by Actelion Pharmaceuticals US, Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- SELEXIPAG
- Manufacturer
- Actelion Pharmaceuticals US, Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc1166215-602-06
- ndc1166215-602-14
- ndc1166215602061 BOTTLE in 1 CARTON (66215-602-06) / 60 TABLET, COATED in 1 BOTTLE
- ndc1166215602141 BOTTLE in 1 CARTON (66215-602-14) / 140 TABLET, COATED in 1 BOTTLE
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Selexipag in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsSelexipag Abdi 1.000 microgram filmomhulde tablettenAbdi Farma GmbH
- SwedenSelexipag Accord 1000 mikrogram Filmdragerad tablettAccord Healthcare B.V.
- CzechiaSELEXIPAG ACCORDACCORD HEALTHCARE POLSKA Sp. z o.o., Varšava
- PolandSelexipag AccordAccord Healthcare Polska Sp. z o.o.
- SpainSELEXIPAG ACCORD 1000 MICROGRAMOS COMPRIMIDOS RECUBIERTOS CON PELICULA EFGAccord Healthcare S.L.U.
- IrelandSelexipag Accord 1 000 microgram film-coated tabletsAccord Healthcare Ireland Ltd.
- IcelandSelexipag STADASTADA Arzneimittel AG
- FinlandUptraviJanssen-Cilag International NV
Authorised across Europe · EMA
The same active substance is authorised in 19 EEA countries. Names it is sold under:
- Austria · Selexipag Ratiopharm
- Cyprus · Selexipag Accord
- Denmark · Selexipag Accord, Selexipag Stada
- Estonia · Selexipag Stada
- Spain · Selexipag Accord, Selexipag Stada
- Greece · Xipeno
- Croatia · Seleksipag Accord
- Ireland · Selexipag Accord, Selexipag Clonmel
- Iceland · Selexipag Stada, Uptravi
- Italy · Selexipag Accord, Selexipag Eg
- Liechtenstein · Uptravi
- Lithuania · Selexipag Stada
- Latvia · Selexipag Stada
- Malta · Selexipag Clonmel
- Netherlands · Seleksipag Accord, Selexipag Abdi
- Norway · Selexipag Accord, Selexipag Stada
- Poland · Selexipag, Selexipag Accord
- Portugal · Selexipag Accord, Selexipag Teva
- Sweden · Selexipag, Selexipag Accord
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e9f0b7f3-faa4-490a-99f2-4393d214fd15 GET /v1/drugs/e9f0b7f3-faa4-490a-99f2-4393d214fd15?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "200",
"substance": "SELEXIPAG",
"productndc": "66215-602",
"dosage_form": "TABLET, COATED",
"dea_schedule": null,
"strength_unit": "ug/1",
"application_number": "NDA207947",
"marketing_category": "NDA"
}See everything about selexipag.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.